You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 30 No. 3, March 1974 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Mixed Anxiety-Depression

Fact or Myth?

Robert W. Downing, PhD; Karl Rickels, MD

Arch Gen Psychiatry. 1974;30(3):312-317.


Abstract



This study is concerned with factors affecting the type of psychotropic medication prescribed for neurotic outpatients with a diagnosis of "mixed anxiety-depression." The sample includes 122 patients assigned to clinical trials with anxiolytics (anxiety study group) and 149 patients assigned to trials with antidepressants (depression study group).

Anxiety and depression dominated the symptom profiles of all patients, but in anxiety study patients anxiety was the more severe of the two symptoms, while in depression study patients depression was the more severe. For physician measures, depression differed more sharply across groups; for patient measures anxiety made the greater contribution to between-group differences.

Multivariate analyses revealed configurational group differences involving anxiety, depression, and insomnia and indicated that information concerning previous treatment response played an additional role in treatment assignment.



Author Affiliations



Philadelphia

From the Psychopharmacology Research Unit, Philadelphia General Hospital, and the Department of Psychiatry, University of Pennsylvania, Philadelphia.


Footnotes



Accepted for publication Nov 5, 1973.

Reprint requests to 203 Piersol Bldg, University Hospital, 3400 Spruce St, Philadelphia 19104 (Dr. Downing).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship Between Anxiety Disorders and Depressive Disorders in Patients With Cerebrovascular Injury
Starkstein et al.
Arch Gen Psychiatry 1990;47:246-251.
ABSTRACT  

Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders: I. Efficacy in Depressed Outpatients
Lipman et al.
Arch Gen Psychiatry 1986;43:68-77.
ABSTRACT  

Panic Disorder and Major Depression: Increased Risk of Depression, Alcoholism, Panic, and Phobic Disorders in Families of Depressed Probands With Panic Disorder
Leckman et al.
Arch Gen Psychiatry 1983;40:1055-1060.
ABSTRACT  

Psychiatric Diagnoses (Research Diagnostic Criteria) in Symptomatic Volunteers
Barrett
Arch Gen Psychiatry 1981;38:153-157.
ABSTRACT  

Review Notions of Neurosis: A Comparison of Community Cases with Declared Patients
Jones
Aust N Z J Psychiatry 1980;14:97-100.
ABSTRACT  

Benzodiazepines in Depressive Disorders
Schatzberg and Cole
Arch Gen Psychiatry 1978;35:1359-1365.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.